Premenopausal plasma ferritin levels, HFE polymorphisms, and risk of breast cancer in the nurses' health study II
- PMID: 24443403
- PMCID: PMC3951649
- DOI: 10.1158/1055-9965.EPI-13-0907
Premenopausal plasma ferritin levels, HFE polymorphisms, and risk of breast cancer in the nurses' health study II
Abstract
Background: Evidence from the Nurses' Health Study II (NHSII) suggests that red meat consumption is associated with increased breast cancer risk in premenopausal women. Iron may be responsible by contributing to oxidative stress or effects on immune function.
Methods: We conducted a case-control study nested within the NHSII, examining prediagnostic plasma ferritin (n = 795 cases, 795 controls), 15 hemochromatosis gene (HFE) single-nucleotide polymorphisms (SNP; n = 765 cases, 1,368 controls), and breast cancer risk. Cases were diagnosed after providing blood samples between 1996 and 1999. ORs and 95% confidence intervals (CI) were calculated for ferritin levels by conditional logistic regression and for HFE SNPs by unconditional logistic regression.
Results: We did not observe a significant association between ferritin levels and breast cancer (top vs. bottom quartile multivariate OR: 1.05; 95% CI, 0.77-1.45; PTrend = 0.77). Results did not change when restricted to women who were premenopausal at blood draw, and were similar when cases were examined by hormone receptor status, and menopausal status at diagnosis. No HFE SNPs were significantly associated with breast cancer in a log-additive manner. Among controls, ferritin levels were nominally associated with SNPs rs9366637 (PTrend = 0.04), rs6918586 (PTrend = 0.06), and rs13161 (PTrend = 0.07), but results did not remain significant after adjusting for multiple testing.
Conclusions: Ferritin levels and HFE SNPs were not associated with breast cancer risk in this population.
Impact: Components of red meat other than iron are likely responsible for its positive association with breast cancer in premenopausal women.
©2014 AACR.
Conflict of interest statement
The authors have no conflicts of interest to disclose.
References
-
- Fleming DJ, Jacques PF, Tucker KL, Massaro JM, D’Agostino RB, Sr, Wilson PW, et al. Iron status of the free-living, elderly Framingham Heart Study cohort: an iron-replete population with a high prevalence of elevated iron stores. Am J Clin Nutr. 2001;73:638–46. - PubMed
-
- Huang X. Iron overload and its association with cancer risk in humans: evidence for iron as a carcinogenic metal. Mutat Res. 2003;533:153–71. - PubMed
-
- Liehr JG, Jones JS. Role of iron in estrogen-induced cancer. Curr Med Chem. 2001;8:839–49. - PubMed
-
- McCord JM. Iron, free radicals, and oxidative injury. Semin Hematol. 1998;35:5–12. - PubMed
-
- Reizenstein P. Iron, free radicals and cancer. Med Oncol Tumor Pharmacother. 1991;8:229–33. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
